Swagata Kar

1.6k total citations · 1 hit paper
22 papers, 250 citations indexed

About

Swagata Kar is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Swagata Kar has authored 22 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 7 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Swagata Kar's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (3 papers). Swagata Kar is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (3 papers). Swagata Kar collaborates with scholars based in United States, India and Nepal. Swagata Kar's co-authors include Mark G. Lewis, Hanné Andersen, Amanda J. Martinot, Yoshihiro Kawaoka, Dan H. Barouch, Victoria Giffin, Mehul S. Suthar, Peter Halfmann, Lisa H. Tostanoski and Mazuba Siamatu and has published in prestigious journals such as Nature, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Swagata Kar

15 papers receiving 248 citations

Hit Papers

Reduced pathogenicity of the SARS-CoV-2 omicron variant i... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swagata Kar United States 8 181 51 44 44 33 22 250
April M. Babka United States 5 194 1.1× 27 0.5× 58 1.3× 38 0.9× 25 0.8× 8 261
Mariana González-Hernández Germany 8 205 1.1× 24 0.5× 64 1.5× 22 0.5× 14 0.4× 13 254
Ellen L. Suder United States 4 224 1.2× 70 1.4× 57 1.3× 75 1.7× 15 0.5× 6 303
Mrunal Sakharkar United States 6 232 1.3× 84 1.6× 79 1.8× 43 1.0× 13 0.4× 8 289
Jacob Berrigan United States 4 144 0.8× 61 1.2× 30 0.7× 61 1.4× 12 0.4× 7 221
Irene P. Chen United States 8 226 1.2× 38 0.7× 37 0.8× 129 2.9× 13 0.4× 10 327
Seth A. Hawks United States 10 157 0.9× 38 0.7× 40 0.9× 46 1.0× 95 2.9× 16 284
Yan Shan Leong Singapore 6 157 0.9× 51 1.0× 18 0.4× 44 1.0× 24 0.7× 7 192
Nazia Thakur United Kingdom 11 213 1.2× 41 0.8× 95 2.2× 48 1.1× 13 0.4× 18 288
Marion Ferren France 9 193 1.1× 61 1.2× 187 4.3× 69 1.6× 31 0.9× 13 370

Countries citing papers authored by Swagata Kar

Since Specialization
Citations

This map shows the geographic impact of Swagata Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swagata Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swagata Kar more than expected).

Fields of papers citing papers by Swagata Kar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swagata Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swagata Kar. The network helps show where Swagata Kar may publish in the future.

Co-authorship network of co-authors of Swagata Kar

This figure shows the co-authorship network connecting the top 25 collaborators of Swagata Kar. A scholar is included among the top collaborators of Swagata Kar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swagata Kar. Swagata Kar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Addetia, Amin, Lisa Perruzza, Kaitlin R. Sprouse, et al.. (2025). Potent neutralization of Marburg virus by a vaccine-elicited antibody. Nature. 650(8101). 459–469.
2.
Soni, Dharmendra Kumar, et al.. (2025). Suppression of miR-155 Attenuates Lung Cytokine Storm Induced by SARS-CoV-2 Infection. Journal of Interferon & Cytokine Research. 45(4). 150–161.
3.
Sui, Yongjun, et al.. (2025). Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters. Frontiers in Immunology. 16. 1514845–1514845.
4.
Culiat, Cymbeline T., Dharmendra Kumar Soni, Mark D. Wienhold, et al.. (2024). NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune response, and the HIF-1α hypoxia pathway to promote healing in viral-induced lung injury. Biochemical and Biophysical Research Communications. 744. 151198–151198.
5.
Sood, Subeena, Majed Matar, Kempaiah Rayavara, et al.. (2024). Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer. Vaccine. 42(6). 1300–1310.
6.
Chiuppesi, Flavia, John A. Zaia, Mindy Kha, et al.. (2024). Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. SHILAP Revista de lepidopterología. 4(1). 19–19. 9 indexed citations
7.
Hamilton, Melissa, Emily M. Webb, M. Peterson, et al.. (2024). Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque. Journal of General Virology. 105(7).
8.
Berry, Catherine, Vincent Pavot, Natalie G. Anosova, et al.. (2023). Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters. SHILAP Revista de lepidopterología. 3(1). 75–75. 2 indexed citations
9.
Sui, Yongjun, Hanné Andersen, Yonas Bekele, et al.. (2023). Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants. Frontiers in Immunology. 14. 1154496–1154496. 6 indexed citations
10.
Wussow, Felix, Mindy Kha, Tae Hyun Kim, et al.. (2023). Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants. npj Vaccines. 8(1). 41–41. 15 indexed citations
11.
Hasanpourghadi, Mohadeseh, Wynetta Giles‐Davis, Zhiquan Xiang, et al.. (2022). Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19. Microbes and Infection. 25(4). 105082–105082. 9 indexed citations
12.
Shi, Guoli, Abhilash I. Chiramel, Tiansheng Li, et al.. (2022). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. Journal of Clinical Investigation. 132(24). 24 indexed citations
13.
McMahan, Katherine, Victoria Giffin, Lisa H. Tostanoski, et al.. (2022). Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters. Med. 3(4). 262–268.e4. 119 indexed citations breakdown →
14.
Wussow, Felix, Mindy Kha, Vu H. Nguyen, et al.. (2022). COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants. iScience. 25(6). 104457–104457. 6 indexed citations
15.
Brumeanu, Teodor‐D., Pooja Vir, Swagata Kar, et al.. (2022). Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19. Human Vaccines & Immunotherapeutics. 18(5). 2048622–2048622. 7 indexed citations
16.
Torres, Jonathan L., Yijia Li, Alex Van Ry, et al.. (2021). One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization. Emerging Microbes & Infections. 10(1). 2016–2029. 12 indexed citations
17.
Kar, Swagata, Jesús Colino, & Clifford M. Snapper. (2016). Distinct Cellular Pathways for Induction of CD4+ T Cell–Dependent Antibody Responses to Antigen Expressed by Intact Bacteria Versus Isolated Soluble Antigen. The Journal of Immunology. 196(10). 4204–4213. 3 indexed citations
18.
Biswas, Moanaro, Swagata Kar, Rupa Singh, et al.. (2009). Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. Journal of Medical Virology. 82(2). 304–310. 34 indexed citations
19.
Kar, Swagata, et al.. (1996). FIELD METHOD FOR CONCENTRATING MYCOBACTERIUM LEPRAE IN SKIN BIOPSY SPECIMENS.. PubMed. 32. 18–23.
20.
Ramasamy, Ranjan, et al.. (1983). Surface antigens on a Kenyan strain of Leishmania donovani.. PubMed. 60(4). 238–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026